16,23-Cyclocholestan-15-one,2,3,6,7,23-pentahydroxy-, (2b,3a,5a,6a,7b,14b,16a,23b)- (9CI) (163436-60-0)

Identification
Name:	16,23-Cyclocholestan-15-one,2,3,6,7,23-pentahydroxy-, (2b,3a,5a,6a,7b,14b,16a,23b)- (9CI)
Synonyms:	XestobergesterolC
CAS:	163436-60-0
Molecular Formula:	C27H44 O6
Molecular Structure:
Properties
Safety Data

Other Product

16,23-Cyclocholestan-15-one,1,2,3,6,7,23-hexahydroxy-, (1b,2b,3a,5a,6a,7b,14b,16a,23b)- (9CI)
16,23-Cyclocholestan-15-one,3,6,7,23-tetrahydroxy-, (3a,5a,6a,7b,14b,16a,23b)- (9CI)
Kaur-16-en-15-one,2,6,7,11-tetrakis(acetyloxy)-3-hydroxy-, (2b,3b,6a,7b,11b)- (9CI)
Formamide, N-[(3b,5a,23b)-23-hydroxysolanidan-3-yl]- (9CI)
Acetamide, N-[(3b,5a,23b)-23-hydroxysolanidan-3-yl]- (9CI)
Benzenediazonium,4-[2-[[(1b,3b,5b,11a,14b)-20,23-epoxy-1,5,11,14,19-tetrahydroxy-23-oxo-24-norchol-20(22)-en-3-yl]oxy]hexahydro-6-hydroxy-7-methyl-1,4-oxazepin-4-yl]-,[2R-(2a,6a,7b)]- (9CI)
Kaur-16-en-15-one,2,3,6,7-tetrakis(acetyloxy)-11-hydroxy-, (2b,3b,6a,7b,11b)- (9CI)
Kaur-16-en-15-one,2,3,6-tris(acetyloxy)-7,11-dihydroxy-, (2b,3b,6a,7b,11b)- (9CI)
Kaur-16-en-15-one,2,6,11-tris(acetyloxy)-3,7-dihydroxy-, (2b,3b,6a,7b,11b)- (9CI)
Kaur-16-en-15-one,2,3,6,7,11-pentakis(acetyloxy)-13-hydroxy-, (2b,3b,6a,7b,11b)- (9CI)
24-Norchol-9(11)-ene-2,3,6-triol,14-methyl-23-[2-methyl-1-(1-methylethyl)cyclopropyl]-, tris(hydrogen sulfate),(2b,3a,5a,6a)- (9CI)
24-Norchol-8-en-3-one,23-[(1R,2S,4R,6R)-4-[(2b,3b,5a,6a,20S)-3,19-epoxy-2,3-dihydroxy-4,4-dimethyl-6-(sulfooxy)pregn-8-en-20-yl]-1,7,7-trimethyl-3,8-dioxabicyclo[4.2.1]non-2-yl]-2-hydroxy-4,4-dimethyl-6-(sulfooxy)-,disodium salt, (2b,5a,6a)- (9CI)
24-Norchol-9(11)-ene-2,3,4,6-tetrol,14-methyl-23-[2-methyl-1-(1-methylethyl)cyclopropyl]-, 2,3,6-tris(hydrogensulfate), sodium salt (1:3), (2b,3a,4b,5a,6a)-
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
Pregn-8-en-3-one,20-[(1R,2S,4R,6R)-2-[(2b,3b)-3,19-epoxy-2,3-dihydroxy-4,4-dimethyl-24-norchola-5,8-dien-23-yl]-1,7,7-trimethyl-3,8-dioxabicyclo[4.2.1]non-4-yl]-2-hydroxy-4,4-dimethyl-6-(sulfooxy)-,monosodium salt, (2b,5a,6a,20S)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2,3,16,20,25-pentahydroxy-4,9,14-trimethyl-, (9b,16a,23E)- (9CI)
Ergost-23-ene-2,3,6-triol,25-(1-methylethyl)-, tris(hydrogen sulfate), sodium salt (1:1), (2b,3a,5a,6a,23E)-
Kaur-16-en-15-one,3-(acetyloxy)-2,6,11-trihydroxy-, (2b,3b,6a,11a)- (9CI)
Aspidospermidine-3-carboxylicacid, 4-(acetyloxy)-6,7-didehydro-15-[(3b,5a,7b,12R,19a)-1,2-didehydro-7-ethyl-7-hydroxy-3-(methoxycarbonyl)-20,21-dinoraspidospermidin-3-yl]-1-formyl-3-hydroxy-16-methoxy-,methyl ester, (2b,3b,4b,5a,12R,19a)-(9CI)
Aspidospermidine-3-carboxylicacid, 4-(acetyloxy)-6,7-didehydro-15-[(3b,5a,7b,12R,19a)-1,2-didehydro-7-ethyl-7-hydroxy-3-(methoxycarbonyl)-20,21-dinoraspidospermidin-3-yl]-3-hydroxy-16-methoxy-1-methyl-,methyl ester, (2b,3b,4b,5a,12R,19a)-(9CI)